Epidemiologic Transitions and Preventive Frameworks in Latin America: Structural Determinants, Internal Medicine and Population Health Challenges in the 21st Century
DOI:
https://doi.org/10.64784/066Keywords:
population, health, epidemiologic transitions, noncommunicable diseases, preventive strategies, social determinants, epidemiologic intelligence, Latin America, Mexico, Colombia, EcuadorAbstract
Population health in the 21st century is shaped by the convergence of chronic disease burdens, emergent infectious threats, environmental pressures and widening social inequities. This review analyzes epidemiologic dynamics in Mexico, Colombia and Ecuador within the broader global context, integrating findings from mortality patterns, behavioral and metabolic risk profiles, structural determinants and health-system capacities. Results indicate that the three countries share an advanced epidemiologic transition dominated by noncommunicable diseases, while still experiencing persistent communicable threats and injury-related mortality. Elevated levels of obesity, hypertension and physical inactivity contribute to an intensified risk environment compared with global averages, reflecting rapid lifestyle and urban transitions. Social determinants—including inequality, urbanization and variable access to primary care—further differentiate population vulnerabilities. Additionally, substantial variation in preventive capacity and epidemiologic intelligence underscores systemic disparities in preparedness and response. The findings highlight the need for integrated, multilevel preventive strategies that address metabolic risks, strengthen primary care, reduce inequities and modernize surveillance systems. This study contributes to a nuanced understanding of how diverse structural and epidemiologic forces shape population health trajectories in the 21st century.
References
[1] V. M. Pain et al., “Global health: evolution and strategic priorities,” The Lancet, vol. 395, no. 10223, pp. 1469–1475, 2020, doi: 10.1016/S0140-6736(20)30664-1.
[2] C. J. L. Murray et al., “Global burden of 87 risk factors, 1990–2019: a systematic analysis,” The Lancet, vol. 396, no. 10258, pp. 1223–1249, 2020, doi: 10.1016/S0140-6736(20)30752-2.
[3] World Health Organization, “World health statistics 2023: monitoring health for the SDGs,” WHO, Geneva, 2023. [Online]. Available: https://www.who.int/data
[4] J. M. Sharfstein, “Public health leadership in the COVID-19 era,” JAMA, vol. 324, no. 13, pp. 1259–1260, 2020, doi: 10.1001/jama.2020.17402.
[5] M. S. E. Homer et al., “Primary health care and public health: foundations of universal health coverage,” The Lancet, vol. 394, no. 10199, pp. 2210–2223, 2019, doi: 10.1016/S0140-6736(19)31801-8.
[6] S. M. Z. Saha et al., “Climate change, population health, and epidemiologic transitions,” Annual Review of Public Health, vol. 43, pp. 123–141, 2022, doi: 10.1146/annurev-publhealth-020421-020928.
[7] J. P. Koplan et al., “Towards a common definition of global health,” The Lancet, vol. 373, no. 9679, pp. 1993–1995, 2009, doi: 10.1016/S0140-6736(09)60332-9.
[8] A. Marmot, “Social determinants of health inequalities,” The Lancet, vol. 365, no. 9464, pp. 1099–1104, 2005, doi: 10.1016/S0140-6736(05)74334-3.
[9] R. Horton, “Offline: COVID-19 is not a pandemic but a syndemic,” The Lancet, vol. 396, no. 10255, p. 874, 2020, doi: 10.1016/S0140-6736(20)32000-6.
[10] G. A. Mensah, “Noncommunicable diseases in the 21st century: global epidemiology, prevention, and control,” Cardiology Clinics, vol. 35, no. 2, pp. 165–179, 2017, doi: 10.1016/j.ccl.2016.12.002.
[11] D. Webb Hooper, “COVID-19 and racial/ethnic disparities,” JAMA, vol. 323, no. 24, pp. 2466–2467, 2020, doi: 10.1001/jama.2020.8598.
[12] K. E. Jones et al., “Global trends in emerging infectious diseases,” Nature, vol. 451, no. 7181, pp. 990–994, 2008, doi: 10.1038/nature06536.
[13] S. Bhatt et al., “The effect of malaria control on Plasmodium falciparum in Africa, 2000–2015,” Nature, vol. 526, no. 7572, pp. 207–211, 2015, doi: 10.1038/nature15535.
[14] F. Meslé et al., “Mortality impacts of the COVID-19 pandemic in 2020,” Nature, vol. 593, pp. 151–158, 2021, doi: 10.1038/s41586-021-03426-3.
[15] G. Danaei et al., “The preventable causes of death in the United States: comparative risk assessment,” PLoS Medicine, vol. 6, no. 4, e1000058, 2009, doi: 10.1371/journal.pmed.1000058.
[16] L. Etienne et al., “Universal health coverage in the Americas: challenges and strategies,” Rev Panam Salud Publica, vol. 41, pp. 1–8, 2017. [Online]. Available: https://iris.paho.org
[17] A. J. Cohen et al., “Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution,” The Lancet, vol. 389, no. 10082, pp. 1907–1918, 2017, doi: 10.1016/S0140-6736(17)30505-6.
[18] C. Dye, “After 2015: infectious diseases in a new era of health and development,” Philosophical Transactions of the Royal Society B, vol. 369, no. 1645, pp. 20130426, 2014, doi: 10.1098/rstb.2013.0426.
[19] L. R. Salgado et al., “Epidemiologic intelligence systems for outbreak detection,” Emerging Infectious Diseases, vol. 28, no. 6, pp. 1155–1163, 2022, doi: 10.3201/eid2806.212302.
[20] D. A. McKenzie et al., “Urbanization, population density, and infectious disease transmission: a systematic review,” PLOS ONE, vol. 16, no. 11, e0259381, 2021, doi: 10.1371/journal.pone.0259381.
